Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Carrier Global enters its October 29 earnings with the most consequential analyst move of the past month landing this morning, and short sellers accelerating bets against the stock at their fastest pace in weeks.
Goldman Sachs crossed the line that the prior note flagged as a risk. Joe Ritchie downgraded CARR from Buy to Neutral this morning, cutting his target from $74 to $61. That follows a September 30 trim from $85 to $74 that kept the Buy intact. The double-move in two weeks is the clearest expression of eroding conviction at the top end of the bull camp. RBC Capital also cut its Outperform target today, from $82 to $72. JP Morgan reinstated coverage on October 9 at Neutral with a $61 target, landing at the same level as Goldman's fresh call. The Street picture is now weighted toward caution: the consensus mean target has fallen to $73.66 against a stock at $55.03, implying theoretical upside on paper, but the direction of travel across every recent revision is down. Bernstein sits at $64, JPMorgan and Goldman both at $61, Morgan Stanley at $60. The bulls still on the board, Citigroup at $80 and RBC at $72, are increasingly outliers in terms of target level, even while keeping positive ratings.
Short interest has moved sharply in the same direction as the analyst rewrites. Shorts have added roughly 60% to their positions over the past month, with the estimate now at 2.55% of free float. That is not a crowded short by any absolute measure, but the rate of change is notable: SI climbed 27% over the past week alone, the steepest weekly build in the trailing 30-day window. Cost to borrow has risen in tandem, up 30% over the week to 0.51%, though it remains inexpensive in absolute terms. Borrow availability is extremely loose, running at over 4,000% of short interest, meaning there is no mechanical constraint on further short-side position building. The borrow market tells you shorts can add freely if they want to; the question is whether the Goldman downgrade gives them fresh permission.
Options positioning offers a mild counterpoint to the bearish momentum. The put/call ratio is 2.59, well above one, but it has actually eased from the peaks seen in late September, when the PCR touched 3.59, its highest of the past year. The 20-day average is 2.72, so the current reading is fractionally below its own recent mean, a z-score of -0.32. That means options traders are not adding fresh downside hedges at this moment, even as shorts build and analysts cut. The PCR compression since mid-September may simply reflect that the defensive positioning was put on earlier, when the stock was higher.
The stock has lost 4.2% over the past month and 1.9% over the week, closing at $55.03. Peer LII dropped 4.2% over the same five sessions, while TT was essentially flat, up 0.3%. The building products sector is broadly under pressure, but CARR has kept pace with its most correlated peer rather than leading the decline. The ORTEX short score ticked up to 34.6 this week from 32.4 a week ago, a modest but consistent move higher. The Viessmann Generations Group remains on the 13D register with a 4.57% stake, down from 5.84% previously following the May share sale. As a 13D filer, Viessmann holds activist-classified status under SEC disclosure rules, though stakes are as last disclosed and positions can fall below 5% without a subsequent filing.
The October 29 print is now the fulcrum. Last quarter's result moved the stock down 13.6% on the day, a reaction that still hangs over sentiment. The quarter before that produced a 9.5% gain. With Goldman freshly on the sidelines, short interest at a one-month high, and the consensus target still well above the current price, how management addresses the residential market outlook and any update on the HVAC price-fixing litigation will determine whether the gap between stock price and analyst targets starts to close or widens further.
See the live data behind this article on ORTEX.
Open CARR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.